ReviewNano-micro letters2025
Recent Advancements and Perspectives of Low-Dimensional Halide Perovskites for Visual Perception and Optoelectronic Applications.
Review in Nano-micro letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Comparing the structure and photoluminescence properties of Bi-doped lead-free double perovskites prepared by solution-based synthesis and green mechanochemistry.Scientific reports · 2026Article
- Perovskite Heterostructures for Optoelectronic Applications.Advanced materials (Deerfield Beach, Fla.) · 2026Review
- Organic Cation Conformation-Modulated Dimensionality in Chiral Metal Halides for Enhancing Linear and Nonlinear Chiroptical Properties.Angewandte Chemie (International ed. in English) · 2026Article
- Diamine-Mediated Synergistic Engineering of Orientation and Interfacial Field of 3D/1D Heterojunctions for Efficient Perovskite Photovoltaics.Nano-micro letters · 2026Article
- Mesh-Architected Structurally Flexible Pb(ZrNano-micro letters · 2026Article
- Prediction of Bandgap and Key Feature Analysis of Lead-Free Double Perovskite Oxides Based on Deep Learning.Molecules (Basel, Switzerland) · 2026Article
- Mid-Infrared Transparent Materials: from Mechanisms to Cutting-Edge Applications.Nano-micro letters · 2026Review
- Biomimetic Synapses Based on Halide Perovskites for Neuromorphic Vision Computing: Materials, Devices, and Applications.Nano-micro letters · 2026Review
- Electronic and Optical Properties of 2D-TMD/Janus Heterostructures Under the Influence of an Electric Field: First-Principles Calculations.Materials (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Low-dimensional (LD) halide perovskites have attracted considerable attention due to their distinctive structures and exceptional optoelectronic properties, including high absorption coefficients, extended charge carrier diffusion lengths, suppressed non-radiative recombination rates, and intense photoluminescence. A key advantage of LD perovskites is the tunability of their optical and electronic properties through the precise optimization of their structural arrangements and dimensionality. This review systematically examines recent progress in the synthesis and optoelectronic characterizations of LD perovskites, focusing on their structural, optical, and photophysical properties that underpin their versatility in diverse applications. The review further summarizes advancements in LD perovskite-based devices, including resistive memory, artificial synapses, photodetectors, light-emitting diodes, and solar cells. Finally, the challenges associated with stability, scalability, and integration, as well as future prospects, are discussed, emphasizing the potential of LD perovskites to drive breakthroughs in device efficiency and industrial applicability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.